Congrats Dr. Matt Gallovic!
Matt Gallovic successfully defended his PhD thesis, “Acid-Sensitive Polymer Microparticles for Subunit Vaccine Delivery” today.
Matt Gallovic successfully defended his PhD thesis, “Acid-Sensitive Polymer Microparticles for Subunit Vaccine Delivery” today.
The Ainslie Lab is pleased to announce that we have received Eshelman Institute for Innovation Tier 1 funding to develop long-acting HIV therapies.
Check out our latest publication on a new family of acid-degradable polymers for vaccine application. http://pubs.rsc.org/en/content/articlelanding/2016/TB/C6TB00745G#!divAbstract
The Ainslie Lab is pleased to announce we were just awarded a collaborative NIH R01 with Lead Investigator Dr. Shawn Hingtgen (UNC Eshelman School of Pharmacy). The award is titled: “Nanofiber matrices to improve neural stem cell-mediated cancer therapy”. We … Read more
Our latest publication looks into creating a long acting injectable for the release of the HIV protease inhibitor Saquinavir. For this we formed a microconfetti acetalated dextran that could be loaded with up to 50% drug. http://link.springer.com/article/10.1007/s11095-016-1936-y?wt_mc=internal.event.1.SEM.ArticleAuthorOnlineFirst
Congratulation to Graham Collins for receiving UNC’s Taylor Summer Undergraduate Research Fellowship #HonorsCarolina. To celebrate, here is a picture of Graham and the rest of the Ainslie Lab!
The Ainslie Lab welcomes two new graduate students! Welcome Kathryn Moore, a Biomedical Engineering Graduate Student, and Erica Pino, a Pharmaceutical Science Graduate Student.
The Ainslie Lab is pleased to announce they were just award nearly $6 million by the NIH to study host-directed treatments for drug resistant bacterial infections. This grant would not be possible without Co-PI Dr. Bruce Blough at RTI International, … Read more
Congrats to Kaylyn Pogson for winning Best Poster for “Fabrication and Characterization of Drug Delivery Systems for Resiquimod” at the UNC Celebration of Undergraduate Research!